![Hiroyuki Muroga](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hiroyuki Muroga
Comptroller/Controller/Auditor at Institute of Immunology Co., Ltd.
Hiroyuki Muroga active positions
Companies | Position | Start | End |
---|---|---|---|
Institute of Immunology Co., Ltd.
![]() Institute of Immunology Co., Ltd. Medical SpecialtiesHealth Technology Institute of Immunology Co., Ltd. engages in the manufacture and sale of diagnostic reagents and monoclonal antibodies for research purpose. It develops and produces Enzyme Immunoassay (EIA) kits related to infectious diseases such as hepatitis B as well as those for human hepatocellular growth factor determination. The firm also offers EIA kits for detecting hepatitis E virus antibody and for determining the genotypes of hepatitis B virus and offers immunization of 3 mice, evaluation, fusion, screening, cloning, ascites production and purification services to the research, clinical and medical industries. The company was founded by Tetsuo Nakamura on August 18, 1979 and is headquartered in Tokyo, Japan. | Comptroller/Controller/Auditor | - | - |
Career history of Hiroyuki Muroga
Former positions of Hiroyuki Muroga
Companies | Position | Start | End |
---|---|---|---|
PERSEUS PROTEOMICS INC. | Comptroller/Controller/Auditor | - | - |
Statistics
International
Japan | 3 |
Operational
Comptroller/Controller/Auditor | 2 |
Sectoral
Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
PERSEUS PROTEOMICS INC. | Health Technology |
Private companies | 1 |
---|---|
Institute of Immunology Co., Ltd.
![]() Institute of Immunology Co., Ltd. Medical SpecialtiesHealth Technology Institute of Immunology Co., Ltd. engages in the manufacture and sale of diagnostic reagents and monoclonal antibodies for research purpose. It develops and produces Enzyme Immunoassay (EIA) kits related to infectious diseases such as hepatitis B as well as those for human hepatocellular growth factor determination. The firm also offers EIA kits for detecting hepatitis E virus antibody and for determining the genotypes of hepatitis B virus and offers immunization of 3 mice, evaluation, fusion, screening, cloning, ascites production and purification services to the research, clinical and medical industries. The company was founded by Tetsuo Nakamura on August 18, 1979 and is headquartered in Tokyo, Japan. | Health Technology |
- Stock Market
- Insiders
- Hiroyuki Muroga
- Experience